Publicaciones en las que colabora con Manuel Muro Amador (29)

2021

  1. A high concentration of TGF-β correlates with opportunistic infection in liver and kidney transplantation

    Human Immunology, Vol. 82, Núm. 6, pp. 414-421

  2. Pretransplant ascites and encephalopathy and their influence on survival and liver graft rejection in alcoholic cirrhosis disease

    Archives of Medical Science, Vol. 17, Núm. 3, pp. 682-693

2020

  1. Influence of preformed antibodies in liver transplantation

    Journal of Clinical Medicine, Vol. 9, Núm. 3

2017

  1. CD28 biomarker quantification and expression level profiles in CD4+ T-lymphocytes in solid organ transplantation

    Transplant Immunology, Vol. 42, pp. 9-17

2016

  1. Epidemiology, Evolution, and Long-Term Survival of Alcoholic Cirrhosis Patients Submitted to Liver Transplantation in Southeastern Spain

    Alcoholism: Clinical and Experimental Research, Vol. 40, Núm. 4, pp. 794-805

  2. Pretransplant CD28 Biomarker (Levels of Expression and Quantification of Molecules per Cell) in Peripheral CD4+ T Cells Predicts Acute Rejection Episodes in Liver and Kidney Recipients

    Transplantation Proceedings, Vol. 48, Núm. 9, pp. 2987-2989

2012

  1. Influence of human leukocyte antigen mismatching on rejection development and allograft survival in liver transplantation: Is the relevance of HLA-A locus matching being underestimated?

    Transplant Immunology, Vol. 26, Núm. 2-3, pp. 88-93

2009

  1. HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation

    Transplantation, Vol. 88, Núm. SUPPL. 3

2008

  1. CT60 A/G marker of the 3′-UTR of the CTLA4 gene and liver transplant

    Transplant Immunology, Vol. 18, Núm. 3, pp. 246-249

2007

  1. Impact of Recipient HLA-C in Liver Transplant: A Protective Effect of HLA-Cw*07 on Acute Rejection

    Human Immunology, Vol. 68, Núm. 1, pp. 51-58

2006

  1. HBV and HCV Infections and Acute Rejection Differentially Modulate CD95 and CD28 Expression on Peripheral Blood Lymphocytes After Liver Transplantation

    Human Immunology, Vol. 67, Núm. 11, pp. 884-893

  2. Lack of association between the -403G/A promoter polymorphism in the human CCL5/RANTES chemokine gene in liver transplant outcome

    Transplant International, Vol. 19, Núm. 2, pp. 98-104

  3. Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients

    Tissue Antigens, Vol. 67, Núm. 2, pp. 117-126

2005

  1. Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: Experience of one centre

    Transplant Immunology, Vol. 14, Núm. 2, pp. 91-97

2003

  1. Human leukocyte antigen-C in short- and long- term liver graft acceptance

    Liver Transplantation, Vol. 9, Núm. 3, pp. 218-227

  2. Impact of HLA-C on acute rejection in liver transplantation

    Transplantation Proceedings

  3. Relationship between CDC cross-match in liver recipients and antibody screening by flow cytometry

    Transplantation Proceedings

2002

  1. DQA1 and DPB1 genes polymorphism on acute rejection development in liver transplantation

    Transplantation Proceedings, Vol. 34, Núm. 8, pp. 3302-3303

  2. Discrepancies in HLA-C typing in transplantation: Comparison of PCR-SSP and serology results

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 419-420

  3. Expression of CD95 and apoptosis induction in peripheral blood cells from liver graft recipients

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 280-282